BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 22972936)

  • 1. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).
    Mo JS; Yu FX; Gong R; Brown JH; Guan KL
    Genes Dev; 2012 Oct; 26(19):2138-43. PubMed ID: 22972936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP.
    Hong AW; Meng Z; Yuan HX; Plouffe SW; Moon S; Kim W; Jho EH; Guan KL
    EMBO Rep; 2017 Jan; 18(1):72-86. PubMed ID: 27979971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.
    Yu FX; Zhao B; Panupinthu N; Jewell JL; Lian I; Wang LH; Zhao J; Yuan H; Tumaneng K; Li H; Fu XD; Mills GB; Guan KL
    Cell; 2012 Aug; 150(4):780-91. PubMed ID: 22863277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
    Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
    J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
    Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL
    Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.
    Kim NG; Koh E; Chen X; Gumbiner BM
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11930-5. PubMed ID: 21730131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
    Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
    EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat stress activates YAP/TAZ to induce the heat shock transcriptome.
    Luo M; Meng Z; Moroishi T; Lin KC; Shen G; Mo F; Shao B; Wei X; Zhang P; Wei Y; Guan KL
    Nat Cell Biol; 2020 Dec; 22(12):1447-1459. PubMed ID: 33199845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual regulation between Hippo signaling and actin cytoskeleton.
    Matsui Y; Lai ZC
    Protein Cell; 2013 Dec; 4(12):904-10. PubMed ID: 24248471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
    Lv XB; Liu CY; Wang Z; Sun YP; Xiong Y; Lei QY; Guan KL
    EMBO Rep; 2015 Aug; 16(8):975-85. PubMed ID: 26116754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
    Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
    Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP).
    Oka T; Mazack V; Sudol M
    J Biol Chem; 2008 Oct; 283(41):27534-27546. PubMed ID: 18640976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.